JPRN-UMIN000045547已完成未知
A randomized, placebo-controlled, double blind, parallel study of the effect of lactic acid bacteria on the imbalance and discomfort of mental and physical conditions in healthy peri/post-menopause females - A randomized, placebo-controlled, double blind, parallel study of the effect of lactic acid bacteria on the imbalance and discomfort of mental and physical conditions in healthy peri/post-menopause females
Mibyou Life Science inc0 个研究点目标入组 115 人开始时间: 2022年2月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 115
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45years-old 至 54years-old(—)
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Subjects who are suffering from or treated for diseases that affect menopausal symptoms, including thyroid and psychological disorders 2) Subjects who are suffering from menopausal symptoms due to surgical procedures such as oophorectomy 3) Subjects who are judged by the principal investigator to require treatment such as medication for menopausal symptoms 4) Subjects who had a history of menopausal disorders 5) Subjects who regularly use pharmaceuticals, Food for Specified Health Uses, Foods with Functional Claims, health food, and supplements that affect this study 6) Subjects who have an allergy for the pharmaceuticals and foods that affect this study 7) Subjects who have hypersensitivity reactions for test foods 8) Subjects who drink more than 20 grams of alcohol per day 9) Subjects who smoke more than 20 cigarettes per day 10) Subjects who are unable to refrain from consuming Food for Specified Health Uses, Foods with Functional Claims, and other so-called health foods during the study 11) Subjects who have been participated in other clinical trial or trials, or wish to participate within the study period 12) Subjects who are unable to follow the doctor's instructions or are judged as an inappropriate candidate by the doctor
研究者
相似试验
进行中(未招募)
不适用
Chicken antibodies (IgY) for the eradication of ESBL-Klebsiella pneumoniae and E coli in carriersEUCTR2009-011446-26-SEppsala University
进行中(未招募)
不适用
A study to evaluate the efficacy and safety of the study drug DP-b99 in patients who suffer from acute ischemic strokeEUCTR2009-012025-11-ATD-Pharm Ltd.770
进行中(未招募)
不适用
A study to evaluate the efficacy and safety of the study drug DP-b99 in patients who suffer from acute ischemic strokeEUCTR2009-012025-11-PTD-Pharm Ltd.770
进行中(未招募)
不适用
Study of Sativex for the Treatment of Cancer Related Pain.EUCTR2009-016064-36-BGGW Pharma Ltd380
进行中(未招募)
不适用
A double blind, randomized, placebo-controlled, parallel group,multicenter Phase 3 pivotal study to assess the safety and efficacy of1mg/kg/day intravenous DP-b99 over 4 consecutive days versusplacebo when initiated within nine hours of acute ischemic stroke onset. - MACSIEUCTR2009-012025-11-HUD-Pharm Ltd.770
